瘤病毒:对于多发性骨髓瘤患者来说,一种潜在的突破性免疫疗法
Vincenzo Raimondi1, Rosanna Vescovini1, Mattia Dessena1
1Laboratory of Hematology, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Frontiers in immunology
|November 14, 2024
概括
瘤溶解性病毒疗法为治疗多发性骨髓瘤 (MM) 提供了一个有希望的新途径. 这种方法使用瘤性病毒 (OVs) 向癌细胞并激活免疫系统,解决MM治疗的未满足需求.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫学 癌症免疫学
- 血液性恶性瘤 血液性恶性瘤
背景情况:
- 多发性骨髓瘤 (MM) 尽管在免疫治疗方面取得了进展,但仍然无法治愈,经常复发.
- 瘤病毒 (OV) 通过选择性向和破坏癌细胞,同时刺激免疫反应,显示出潜在的潜力.
研究的目的:
- 在MM中全面审查OV的作用机制.
- 分析对MM的OV治疗的临床前和临床证据.
- 探索OV治疗作为一种免疫治疗方法,单独或与现有治疗相结合.
主要方法:
- 关于多发性骨髓瘤瘤病毒治疗的科学文献的综述.
- 临床前研究分析表明OV对MM细胞的疗效.
- 检查正在进行的临床试验,涉及用于MM治疗的OV.
主要成果:
- 无论是天然的还是转基因的OV都表现出对MM的显著临床前活性.
- 临床试验正在评估MM.的修饰性麻疹病毒,reovirus和囊泡性口腔炎病毒菌株.
- 挑战包括优化病毒传递,克服免疫反应,并确保MM细胞的特异性.
结论:
- 瘤性病毒疗法是MM的有前途的免疫治疗策略.
- 将OV与标准治疗和向治疗相结合可能会提高疗效.
- 需要进一步的研究来克服当前的挑战,并优化对MM的OV治疗.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
